First Trust Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

First Trust Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,342	Closed	-$249K	–	2545
2023 Q2	$249K	Buy	+6,342	New	+$224K	﹤0.01%	2268
2021 Q3	–	Sell	-213,109	Closed	-$1.34M	–	2672
2021 Q2	$1.34M	Sell	213,109 -6,009	-3%	-$38.8K	﹤0.01%	1965
2021 Q1	$1.35M	Buy	219,118 +17,588	+9%	+$107K	﹤0.01%	1879
2020 Q4	$1.39M	Sell	201,530 -8,954	-4%	-$57.3K	﹤0.01%	1753
2020 Q3	$1.19M	Buy	+210,484	New	+$1M	﹤0.01%	1671
2016 Q1	–	Sell	-25,262	Closed	-$1.98M	–	2306
2015 Q4	$1.98M	Buy	+25,262	New	+$1.46M	0.01%	1404

First Trust Advisors's ISEE Position: Q3 2023 in Review

First Trust Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 6,342 shares — an estimated $249K sold.

First Trust Advisors first reported a position in ISEE in Q4 2015 and held it in 6 quarters. The position peaked at $1.98M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

First Trust Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
First Trust Advisors sold 6,342 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $249K.
First Trust Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2015 and held it in 6 quarters.
First Trust Advisors's IVERIC bio, Inc. Common Stock position peaked at $1.98M in Q4 2015.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on First Trust Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.